Vyome Holdings, Inc. (HIND) vs IRIDEX Corporation (IRIX)
A side-by-side comparison of Vyome Holdings, Inc. and IRIDEX Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HIND
Vyome Holdings, Inc.
$1.97HealthcareDelayed quote: Oct 6, 2026, 10:34 AM EDT
IRIX
IRIDEX Corporation
$0.72HealthcareDelayed quote: Oct 6, 2026, 10:23 AM EDT
Total return — HIND vs IRIX
growth of $100 · dividends reinvested · last 10yHIND -100.0% (-84.2%/yr)IRIX -95.2% (-26.2%/yr)IRIX compounded faster over this window
Log scale — wide-divergence pair
HIND IRIX
HIND vs IRIX: by the numbers
- •HIND is the larger company ($14M vs $12M market cap).
- •Both run net losses; IRIX's is the smaller (-6.88% vs -8716.77% net margin).
- •Both shrank revenue over the past five years; IRIX's decline was smaller (-0.57% vs -60.54% CAGR).
Metrics side by side
Valuation
| Metric | HIND | IRIX |
|---|---|---|
| P/S ratio | 106.58 | 0.24 |
| P/B ratio | 2.29 | N/A |
| FCF yield | 3.79% | N/A |
Profitability
| Metric | HIND | IRIX |
|---|---|---|
| Gross margin | 64.68% | 36.23% |
| Operating margin | -859.22% | -5.39% |
| Net margin | -8716.77% | -6.88% |
| ROE | -186.95% | -97.47% |
| ROIC | -57.53% | -19.53% |
Growth (annualized)
| Metric | HIND | IRIX |
|---|---|---|
| Revenue CAGR (5Y) | -60.54% | -0.57% |
| Total return CAGR (5Y) | -92.93% | -38.13% |
Frequently asked
- Which has grown faster, HIND or IRIX?
- Neither grew: over the past five years both shrank revenue, with IRIX's decline the smaller — HIND at a -60.54% CAGR versus IRIX at -0.57%.
- How have HIND and IRIX total returns compared?
- Over the past 5 years, HIND delivered -92.93% and IRIX delivered -38.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.